Michael Sage

Wednesday, April 3, 2019

FDA-approved drug effectively treats rare chronic immune disorder

Small NIH clinical trial conducted in partnership with AstraZeneca.

From https://www.nih.gov/news-events/news-releases/fda-approved-drug-effectively-treats-rare-chronic-immune-disorder



from
https://healthnews010.wordpress.com/2019/04/04/fda-approved-drug-effectively-treats-rare-chronic-immune-disorder/

from https://karlfletcher.blogspot.com/2019/04/fda-approved-drug-effectively-treats.html

from
https://karlfletcher1.tumblr.com/post/183930933723

from https://davidrawlins1.blogspot.com/2019/04/fda-approved-drug-effectively-treats.html

from
https://davidrawlins1.tumblr.com/post/183931084931

from https://ift.tt/2IbRXxH

from
https://jamesprice01.tumblr.com/post/183931226574
Posted by Michael Sage at 10:30 PM
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

About Me

My photo
Michael Sage
All animals are composed of cells, surrounded by a characteristic extracellular matrix composed of collagen and elastic glycoproteins. During development, the animal extracellular matrix forms a relatively flexible framework upon which cells can move about and be reorganised, making the formation of complex structures possible.
View my complete profile

Michael Sage

  • Official Site
  • YouTube
  • WordPress
  • Gravatar
  • Tumblr
  • Diigo
  • Google Drive
  • Weebly
  • Vimeo
  • Alternion
  • Pearltrees
  • Nimbus
  • Giphy
  • OneNote
  • Evernote
  • Disqus
  • Getpocket
  • Instapaper
  • Bitly
  • Pinterest
  • About Me
  • Dropbox
  • IFTTT
Simple theme. Powered by Blogger.